Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evelo Biosciences (EVLO)
:EVLO
Holding EVLO?
Track your performance easily
EVLO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.07
Previous CloseN/A
Volume66.00
Average Volume (3M)1.60K
Market Cap
$9.49K
Enterprise ValueN/A
Total Cash (Recent Filing)$15.54M
Total Debt (Recent Filing)$9.93M
Price to Earnings (P/E)―
Beta37.90
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.35
Shares Outstanding18,982,838
10 Day Avg. Volume68
30 Day Avg. Volume1,600
Standard Deviation0.55
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evelo Biosciences News
Ownership Overview
―
Insiders
51.91% Other Institutional Investors
48.09% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
EVLO FAQ
What was Evelo Biosciences’s price range in the past 12 months?
Evelo Biosciences lowest stock price was $0.02 and its highest was $0.07 in the past 12 months.
What is Evelo Biosciences’s market cap?
Evelo Biosciences’s market cap is $9.49K.
When is Evelo Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Evelo Biosciences’s earnings last quarter?
Currently, no data Available
Is Evelo Biosciences overvalued?
According to Wall Street analysts Evelo Biosciences’s price is currently Overvalued.
Does Evelo Biosciences pay dividends?
Evelo Biosciences does not currently pay dividends.
What is Evelo Biosciences’s EPS estimate?
Evelo Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evelo Biosciences have?
Evelo Biosciences has 18,982,838 shares outstanding.
What happened to Evelo Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Evelo Biosciences?
Currently, no hedge funds are holding shares in EVLO
---
Company Description
Evelo Biosciences
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
---
EVLO Earnings Call
Q4 2023
0:00 / 0:00
---
Adaptimmune Therapeutics
―
Cellectar Biosciences
―
Cyclerion Therapeutics
―
Solid Biosciences
―
Kiniksa Pharmaceuticals
―
---